FDA advierte posible pérdida de visión por medicamentos para bajar de peso; esto responde Novo Nordisk
- Words
- 24
- Chars
- 143
- AI summary
- Yes
Full story
The U.S. Food and Drug Administration warned that weight‑loss drugs could be associated with loss of vision. In an interview with Excélsior, Mike Vivas, the medical director of Novo Nordisk, said that no causal relationship has been proven so far.
En entrevista con Excélsior, Mike Vivas, director médico de Novo Nordisk, explicó que no hay una relación causal demostrada hasta el día de hoy
Open article